Richard Bernstein Advisors LLC Has $3.04 Million Stock Holdings in McKesson Corporation $MCK

Richard Bernstein Advisors LLC trimmed its position in shares of McKesson Corporation (NYSE:MCK) by 49.5% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,930 shares of the company’s stock after selling 3,856 shares during the quarter. Richard Bernstein Advisors LLC’s holdings in McKesson were worth $3,036,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds have also made changes to their positions in the company. GGM Financials LLC acquired a new position in shares of McKesson during the 3rd quarter worth about $25,000. State of Wyoming bought a new stake in shares of McKesson in the second quarter worth $29,000. Hopwood Financial Services Inc. purchased a new position in McKesson during the 3rd quarter worth $31,000. Delos Wealth Advisors LLC purchased a new stake in shares of McKesson during the second quarter valued at $35,000. Finally, Abound Wealth Management raised its stake in shares of McKesson by 104.3% in the third quarter. Abound Wealth Management now owns 47 shares of the company’s stock valued at $37,000 after acquiring an additional 24 shares during the period. Institutional investors and hedge funds own 85.07% of the company’s stock.

McKesson Trading Up 2.4%

McKesson stock opened at $941.19 on Tuesday. The company has a fifty day simple moving average of $884.77 and a 200-day simple moving average of $819.18. McKesson Corporation has a 12-month low of $633.53 and a 12-month high of $999.00. The stock has a market cap of $115.29 billion, a P/E ratio of 27.07, a price-to-earnings-growth ratio of 1.48 and a beta of 0.38.

McKesson (NYSE:MCK) last issued its quarterly earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $9.19 by $0.15. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. The company had revenue of $106.16 billion for the quarter, compared to analyst estimates of $105.98 billion. During the same period in the prior year, the firm earned $8.03 earnings per share. The business’s revenue for the quarter was up 11.4% compared to the same quarter last year. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. As a group, sell-side analysts forecast that McKesson Corporation will post 32.77 earnings per share for the current fiscal year.

McKesson Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 1st. Investors of record on Monday, March 2nd will be issued a dividend of $0.82 per share. The ex-dividend date is Monday, March 2nd. This represents a $3.28 dividend on an annualized basis and a yield of 0.3%. McKesson’s payout ratio is presently 9.43%.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on MCK. Barclays raised their price objective on shares of McKesson from $960.00 to $1,050.00 and gave the stock an “overweight” rating in a report on Wednesday, February 18th. Mizuho boosted their target price on McKesson from $880.00 to $885.00 and gave the stock a “neutral” rating in a research report on Thursday, February 5th. Leerink Partners reaffirmed an “outperform” rating and set a $1,085.00 price target on shares of McKesson in a report on Thursday. Morgan Stanley reissued an “overweight” rating and set a $966.00 price objective on shares of McKesson in a report on Thursday, January 29th. Finally, JPMorgan Chase & Co. lifted their price objective on McKesson from $983.00 to $1,107.00 and gave the stock an “overweight” rating in a research report on Tuesday, February 10th. Thirteen equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $960.93.

Insider Activity

In other McKesson news, EVP Leann B. Smith sold 190 shares of the stock in a transaction dated Tuesday, February 17th. The shares were sold at an average price of $945.00, for a total value of $179,550.00. Following the completion of the sale, the executive vice president owned 2,989 shares in the company, valued at approximately $2,824,605. This represents a 5.98% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CAO Napoleon B. Rutledge, Jr. sold 328 shares of McKesson stock in a transaction that occurred on Friday, February 6th. The stock was sold at an average price of $955.00, for a total value of $313,240.00. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 3,868 shares of company stock valued at $3,743,820 in the last three months. Corporate insiders own 0.08% of the company’s stock.

About McKesson

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.